Related Experiment Video
Updated: Oct 1, 2025
Hypoxic Preconditioning of Marrow-derived Progenitor Cells As a Source for the Generation of Mature Schwann Cells
Published on: June 14, 2017
Human bone marrow mesenchymal stem cells-derived exosomes protect against nerve injury via regulating immune
Jiaping Shu1, Li Jiang2, Meiqiu Wang3
1Department of Pediatrics, School of Medicine, Southeast University, Nanjing 210009, Jiangsu, China.
Insights
Human bone marrow mesenchymal stem cell (hBMSC)-derived exosomes can reduce inflammation and nerve damage in neonatal hypoxic-ischemic brain injury. This study explores their potential to treat this condition by modulating microglia immune responses.
Area of Science:
- Neuroscience
- Immunology
- Regenerative Medicine
Background:
- Neonatal hypoxic-ischemic (HI) brain injury is a severe condition with poorly understood molecular mechanisms.
- Human bone marrow mesenchymal stem cells (hBMSCs) possess immunomodulatory properties.
- Exosomes from hBMSCs may influence microglial polarization and inflammation.
Purpose of the Study:
- To investigate the therapeutic potential of hBMSC-derived exosomes in neonatal HI brain damage.
- To determine the role of hBMSC-exosomes in regulating immune responses and nerve injury.
- To explore the transfer of hBMSC-exosomes into human microglia (HMC).
Main Methods:
- Establishing a neonatal hypoxic-ischemic brain damage model.
- Identifying exosome secretion from hBMSCs.
- Analyzing the transfer of hBMSC-exosomes into HMC.
- Assessing the impact of hBMSC-exosomes on HMC polarization and inflammatory response.
Main Results:
- hBMSC-derived exosomes were successfully transferred into HMC.
- hBMSC-exosomes were found to regulate HMC polarization towards an anti-inflammatory phenotype.
- Exosomes reduced the release of pro-inflammatory factors from HMC.
Conclusions:
- hBMSC-exosomes play a crucial role in modulating the immune response in neonatal HI brain injury.
- These findings suggest hBMSC-exosomes as a potential therapeutic strategy for neonatal brain damage.
- Further research into hBMSC-exosomes could offer new insights into disease progression and treatment.
Abstract:
Neonatal hypoxic-ischemic (HI) brain injury is a serious injury caused by various perinatal factors, which has become a heavy mental burden to the family. The molecular mechanism underlying neonatal hypoxic-ischemic brain injury remains largely unknown. Human bone marrow mesenchymal stem cells (hBMSCs) have caused wide public concern due to the immunomodulatory properties. Exosomes can polarize human microglia and thus changed it into an anti-inflammatory phenotype to reduce the release of pro-inflammatory factors. However, it is unclear whether hBMSCs-exosomes have effect on neonatal hypoxic-ischemic brain injury. In this study, we aimed at investigating the role of hBMSCs-exosomes in regulating immune response and nerve injury in neonatal hypoxic-ischemic brain damage model. In the research, we identified the exosome secretion of hBMSCs could transferred into human microglia (HMC). Moreover, we determined the importance of hBMSCs-exosomes in regulating HMC polarization and inflammatory response. Our research findings might provide a new insight into slowing the disease progression of neonatal hypoxic-ischemic brain injury.
More Related Videos
09:19High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
09:48Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
